October 2, 2009
Life Sciences News @ Gowlings

  Use Twitter?    Follow Gowlings news on Twitter


QLT completes $248-million sale of U.S. subsidiary
http://www.canada.com/vancouversun/news/business/story.html?id=354a7d19-88a4-4271-b65f-21828f68de07&k=45835

BMS, Astra's new diabetes drug hits study target
http://www.reuters.com/article/rbssHealthcareNews/idUSL136183620091002

Allergan challenges federal off-label ban
http://www.reuters.com/article/rbssHealthcareNews/idUSN0129920320091002

Actavis launches generic Lipitor in Spain
http://www.pharmatimes.com/WorldNews/article.aspx?id=16682

EU agency recommends Baxter's H1N1 flu shot
http://www.reuters.com/article/rbssHealthcareNews/idUSL252644320091002

No IPO "resurgence" until 2010-venture cap group
http://www.reuters.com/article/rbssHealthcareNews/idUSN0129536720091001

Takeda sets up ops in Mexico, Turkey, Nordic and Benelux areas
http://www.pharmatimes.com/WorldNews/article.aspx?id=16679

A Rule on Eye Treatment Is Likely to Cost Millions
http://www.nytimes.com/2009/10/02/business/02avastin.html?ref=health

Bayer Labels’ Cancer-Fighting Claim Draws Suit
http://www.nytimes.com/2009/10/02/business/media/02bayer.html?ref=health

Online drug brand abuse is growing, claims new analysis
http://www.pharmatimes.com/WorldNews/article.aspx?id=16680

Scientists urge more Nobel Prizes
http://www.cbc.ca/technology/story/2009/10/01/tech-science-new-nobel-prizes.html

Mahlon Hoagland, RNA Expert, Dies at 87
http://www.nytimes.com/2009/10/02/us/02hoagland.html?_r=1&ref=science

Inventors of bra that turns into gas mask win IgNobel prize
http://www.telegraph.co.uk/science/science-news/6253064/Inventors-of-bra-that-turns-into-gas-mask-win-IgNobel-prize.html


Life Sciences News @ Gowlings is a daily news service that provides news items of interest to those in the life sciences.

If you wish to subscribe/unsubscribe to any Gowlings newsletter, please visit http://www.gowlings.com/e-form/subscribe.asp and complete our subscription form. By your use of this service you agree to the Terms and Conditions set out at http://www.gowlings.com/resources/newsletterList.asp?intNewsletterTypeId=99. If you do not agree with the Terms and Conditions, please do not use the service.

Please contact LifeSciencesNews@gowlingsnewsletters.com with questions or comments.

Gowlings and Personal Information - Gowlings respects your privacy. Please see Gowlings' Privacy Policy for more information about how our Firm manages your personal information.

Gowlings is an acknowledged leader in business law, technology law, intellectual property and advocacy.

Montréal Ottawa Kanata Toronto Hamilton Waterloo Region Calgary Vancouver Moscow London